1 completed, 1 terminated. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Terminated 1 |
| Phase 2 | 2 | Completed 1, Terminated 1 |
Follow Doxylamine: new trials by email Literature Review of Doxylamine trials Research Report on Doxylamine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| E7 TCR T Cells for Human Papillomavirus-Associated Cancers E7 TCR cells, Aldesleukin, Fludarabine - Papillomavirus Infections, Cervical Intraepithelial Neoplasia | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 224 | 2017-01-27 | 2026-03-09 |
| A Phase 1-2 Trial of Cetuximab in Combination With Oxaliplatin, Capecitabine, and Radiation Therapy Followed by Surgery for Locally-advanced Rectal Cancer Cetuximab, Oxaliplatin, Capecitabine - Rectal Cancer, Colo-rectal Cancer | Phase 1 / Phase 2 | Terminated | George Albert Fisher | 23 | 2004-06-01 | 2017-12-08 |
Carcinoma in Situ (1) · Colonic Neoplasms (1) · Papillomavirus Infections (1) · Rectal Neoplasms (1) · Uterine Cervical Dysplasia (1) · Vulvar Diseases (1) · Vulvar Neoplasms (1)
George Albert Fisher (1) · National Cancer Institute (NCI) (1)
United States (2)
Branimir I Sikic, MD (1) · George A Fisher, MD, PhD (1) · Scott M Norberg, D.O. (1)